Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Shock recognition and fluid reassessment

Paediatrics and child health · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Decompensated shock

Reduced consciousness, weak central pulses, hypotension, bradycardia, severe mottling, anuria or worsening respiratory effort signals failing organ perfusion and imminent cardiorespiratory arrest.

Action: Activate the paediatric resuscitation and critical-care team, give high-concentration oxygen, obtain IV access within two attempts or five minutes and use intraosseous access if necessary. Control haemorrhage, give a cause-appropriate 10 mL/kg fluid trial with immediate reassessment, start antibiotics within one hour for septic shock, and move early to blood products, vasoactive support or relief of obstruction according to mechanism.

Synopsis

Identify compensated shock before hypotension, distinguish hypovolaemic, distributive, cardiogenic and obstructive mechanisms, use fluid as a measured treatment trial, and escalate promptly to blood, antimicrobials, vasoactive support or source control when physiology does not recover.

  • Recognise shock from a pattern: heart rate, central and peripheral pulses, refill, skin temperature and colour, blood pressure, consciousness and urine output.
  • A child can be in compensated shock with a normal blood pressure; hypotension, bradycardia or diminished central pulses are late.
  • First-line action is ABCDE, high-concentration oxygen in critical illness, monitoring, glucose and rapid IV or IO access without repeated delay.
  • Classify the likely mechanism as hypovolaemic, distributive, cardiogenic or obstructive because the next treatment differs.
  • For hypovolaemic or distributive shock, use a 10 mL/kg balanced isotonic crystalloid bolus where appropriate and reassess immediately.
  • Reassessment includes heart rate, pulses, refill, blood pressure, consciousness, urine, breathing, crackles and liver edge; record the response and cumulative volume.
  • In cardiogenic shock, fluid need is individual and a cautious 5 mL/kg trial may be used only with early cardiac and critical-care guidance.
  • Haemorrhagic shock needs bleeding control, activation of the massive-haemorrhage pathway and early blood; minimise crystalloid and give tranexamic acid when indicated.
  • Septic shock needs blood cultures if this causes no delay and broad-spectrum antimicrobial treatment within one hour alongside haemodynamic support.
  • Consider vasoactive infusion early and no later than after three to four ineffective 10 mL/kg boluses; peripheral or IO initiation is preferable to waiting for a central line.
  • Obstructive shock improves only when tension pneumothorax, tamponade or another mechanical obstruction is relieved.
  • Renal, cardiac, hepatic and nutritional comorbidity changes fluid distribution and tolerance; smaller trials and earlier specialist support are safer.

Key red flags

Hypotension is a late sign in children; normal blood pressure does not exclude clinically important shock.

Bradycardia, diminished central pulses and reduced consciousness indicate decompensation rather than a reassuring fall in tachycardia.

Rising respiratory rate, crackles, falling saturation or an enlarging liver after fluid suggests overload or myocardial dysfunction.

Uncontrolled external or internal bleeding needs immediate source control and early blood, not repeated crystalloid dilution.

Muffled heart sounds, distended veins, unequal air entry or sudden deterioration during positive-pressure ventilation suggests obstructive shock requiring procedural treatment.

A non-blanching rash, fever or hypothermia, altered behaviour and poor perfusion warrants immediate sepsis management even before laboratory confirmation.

Known congenital heart disease, cardiomyopathy, renal failure or severe malnutrition changes fluid tolerance and requires smaller aliquots and expert input.

Investigation priorities

01
First-line serial clinical perfusion assessmentFirst stepFirst line

Recognise shock and measure response using several age-adjusted variables.

02
First-line glucose, blood gas and lactateFirst line

Detect hypoglycaemia, ventilation failure, acidosis and impaired perfusion rapidly.

Management branches

Initial recognitionTreat before hypotension

Multiple age-adjusted perfusion variables are persistently abnormal.

  1. Activate senior and critical-care help and start monitored ABCDE.
  2. Give high-concentration oxygen for critical illness and obtain IV or prompt IO access.
  3. Check glucose and gas and send cause-directed samples without delaying treatment.
  4. Name the likely shock mechanism and choose the first cause-specific action.

Key medicines

Balanced isotonic crystalloidGive 10 mL/kg IV or IO over less than 10 minutes for appropriate hypovolaemic or distributive shock, then stop and reassess before any repeat; consider only 5 mL/kg cautiously in suspected cardiogenic shock with expert guidance.Do not use a fixed sequence of boluses. Look after each dose for crackles, increasing liver edge, rising respiratory support and absent perfusion response. Cardiac or kidney disease, severe malnutrition and haemorrhage require a modified strategy.
Tranexamic acid for life-threatening traumatic haemorrhageGive 15 to 20 mg/kg IV, maximum 1 g, over 10 minutes as soon as possible and within 3 hours, followed by 2 mg/kg/hour, maximum cumulative infusion 1 g, for at least 8 hours or until bleeding stops under the major-haemorrhage protocol.Use only for the stated haemorrhagic indication, confirm weight and renal function, monitor for thrombosis and seizures, and never allow infusion preparation to delay surgical bleeding control or blood replacement.
Open full textbook →Answer 2 questions
Sources and review status3 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • Resuscitation Council UK 2025 Paediatric Life SupportRecognition by multiple variables, 10 mL/kg aliquots, mechanism-specific shock care, vasoactive escalation and trauma haemorrhage regimen.
  • NICE NG29 Intravenous fluid therapy in childrenUK resuscitation fluid composition, 10 mL/kg volume, reassessment, maintenance and electrolyte monitoring.
  • NICE surveillance review of paediatric fluid bolusesRationale for smaller aliquots, rapid reassessment and early vasoactive support across paediatric shock guidance.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom